Launch of Human NGAL ELISA Kit 036 in a CE/IVD edition - now with controls!
BioPorto Diagnostics is proud to launch an improved Human NGAL ELISA KIT 036 in a CE/IVD edition* with controls (high control and low control) for the in vitro determination of human NGAL in urine or plasma.
*For in vitro diagnostic use only in European countries at this time.
NGAL is an important biomarker for several clinical applications, such as a marker for kidney damage since NGAL levels are raised as much as 48 hours or more before any significant rise in serum creatinine.
Most cited NGAL ELISA kit available
Kit 036 has been available for research use only for several years, and has become increasingly popular in the community, which means that today Kit 036 is the most cited NGAL ELISA Kit available. As a result of this strong clinical references supports the use of NGAL as an early biomarker. Kit 036 has also proved to be very easy to automate on ELISA equipment, such as Grifols, Triturus or the Dynex DSX.
To view the product, click here: http://www.bioporto.com/Products/Product-by-category/ELISA-Kits/NGAL-ELISA-Kit-(human).aspx